LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
Shanghai Pharmaceuticals Holding (601607.SH): Approval for production of Diprophylline Injection.
HK Stock Market Move | BATELAB (02149) fell by over 13%, with profit decreasing nearly 27% year-on-year to 1.22 billion yuan last year.
HK Stock Market Move | In the near future, the internal housing stocks continued to decline. Institutions pointed out that policy expectations were not met and the potential for a small rebound in the market was lacking. The performance of the real estate sector was relatively weak.
Shanghai Pharmaceuticals Holding (601607.SH): Approval for production of Diprophylline Injection.
HK Stock Market Move | BATELAB (02149) fell by over 13%, with profit decreasing nearly 27% year-on-year to 1.22 billion yuan last year.
HK Stock Market Move | In the near future, the internal housing stocks continued to decline. Institutions pointed out that policy expectations were not met and the potential for a small rebound in the market was lacking. The performance of the real estate sector was relatively weak.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
